Naloxone

Take Home Naloxone in the UK

Naloxone (provided under the brand names Prenoxad and Nyxoid in the UK) is a medication used to reverse opioid overdose. Since 2015, this medication has been more widely available in the UK as a ‘take home’ emergency medication.

Find out more

NALOXONE.ORG.UK

This website aims to be a hub for information, guidance, news and research on Take Home Naloxone (THN). The main focus is on THN in the UK, although we have included select pieces of information on the supply of naloxone internationally.

Frequently Asked Questions

How to put someone in the recovery position

PHE Guidance

Updated 18 February 2019
Public Health England have released updated guidance on take home naloxone in the UK, entiled ‘Widening the Availability of Naloxone’. This can be found on the PHE website.
  • Drug services can supply naloxone without a prescription
  • Products that drug services can supply
  • Responsibility for deciding who can supply naloxone
  • People who can be supplied naloxone by a drug service
  • Using naloxone to save a person’s life without their permission
  • Clinical governance in drug treatment services
  • Guidance for hostels, homeless shelters and housing associations
  • Side effects associated with naloxone
View Guidance

Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability

Written on . Posted in .

Substantial proportions of both community and treatment samples of drug misusers have witnessed an overdose death which could have been prevented through prior training in resuscitation techniques and administration of home-based supplies of naloxone. Such a new approach would be supported by most drug misusers. On the basis of these findings, we conclude that it is appropriate to proceed to a carefully constructed trial of naloxone distribution.

Continue Reading
More research  

ACMD young people’s drug use and naloxone provision

Following advice in response to COVID-19, 3 public evidence gathering days which were being arranged by the ACMD to inform reports on young people’s drug use and naloxone provision have been postponed until further notice. We are instead inviting relevant stakeholders to provide written submissions to help support these workstreams.

More Details

News/Updates

Scotland drugs policy minister resolves to reduce horrific death toll

Written on . Posted in , .

Scotland’s new minister for drugs policy, Angela Constance, has said she is determined to see a reduction in the country’s horrific drug-related death toll and significantly more people in treatment within the year.

Continue Reading

Police should carry drugs overdose antidote, says senior officer

Written on . Posted in , .

The overdose antidote naloxone should be made available to all police officers in areas where there is a clear need, the police chiefs’ drug lead has urged after successful pilot schemes.

Continue Reading

Taskforce to Receive 10,000 Free Naloxone Kits

Written on . Posted in , .

Ethypharm, the speciality pharmaceutical company focused on CNS and critical care medicines, has confirmed its offer to supply 10,000 Naloxone kits across 2021 to The Drug Deaths Taskforce. The company, which is the licence holder for Prenoxad Injection, has made the gesture to support the work of the Taskforce in increasing engagement, overdose prevention education and naloxone training and supply with people at risk of overdose and their families. Prenoxad is the world’s first ‘take-home’ naloxone presentation licensed for use in a non-medical setting.

Continue Reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT